Ikena Oncology Inc (IKNA)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
CEO:
Mark Manfredi
Employees:
70
50 NORTHERN AVE., BOSTON, MA 02210
857-343-8292

Ikena Oncology, Inc. focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway.

Data derived from most recent annual or quarterly report
Market Cap 189.496 Million Shares Outstanding36.163 Million Avg 30-day Volume 112.482 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.35
Price to Revenue7.1402 Debt to Equity0.0 EBITDA-40.603 Million
Price to Book Value1.1433 Operating Margin-133.9375 Enterprise Value8.221 Million
Current Ratio8.529 EPS Growth1.052 Quick Ratio8.384
1 Yr BETA 1.6486 52-week High/Low 17.5 / 2.83 Profit Margin-133.4779
Operating Cash Flow Growth-62.604 Altman Z-Score3.3496 Free Cash Flow to Firm -62.912 Million
View SEC Filings from IKNA instead.

View recent insider trading info

Funds Holding IKNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IKNA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

504.5 Thousand total shares from 8 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED GENESIS GP LLC

  • Director
2,098,097 2022-06-22 1

BONITA DAVID P

  • Director
2,098,097 2022-06-22 3

FORMELA JEAN FRANCOIS

  • Director
13,419 2022-06-09 2

RENAUD RONALD C JR

  • Director
13,419 2022-06-09 2

STAMPACCHIA OTELLO

  • Director
13,419 2022-06-09 2

DUKES IAIN D.

  • Director
13,419 2022-06-09 2

WOOSTER RICHARD

  • Director
13,419 2022-06-09 3

KOEHLER MARIA

  • Director
13,419 2022-06-09 2

MARANGO JOTIN CFO & HEAD OF CORP. DEV.

  • Officer
0 2022-04-25 2

OLIVEIRA FRANCISCO PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2022-02-18 1

MANFREDI MARK PRESIDENT & CEO

  • Officer
  • Director
238,900 2022-02-03 1

SANTILLANA SERGIO L. CHIEF MEDICAL OFFICER

  • Officer
70,400 2022-02-02 1

ECSEDY JEFFREY CHIEF DEVELOPMENT OFFICER

  • Officer
59,360 2022-02-02 1

TESSIER MAUDE CHIEF BUSINESS OFFICER

  • Officer
40,000 2022-02-02 2

ZHANG XIAOYAN MICHELLE CHIEF SCIENTIFIC OFFICER

  • Officer
40,000 2022-02-02 5

ATLAS VENTURE FUND X, L.P.

ATLAS VENTURE ASSOCIATES X, L.P.

ATLAS VENTURE ASSOCIATES X, LLC

ATLAS VENTURE FUND XI, L.P.

ATLAS VENTURE ASSOCIATES XI, L.P.

ATLAS VENTURE ASSOCIATES XI, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • 10% Owner
4,919,456 2021-03-30 0

ATLAS VENTURE FUND XI, L.P.

ATLAS VENTURE ASSOCIATES XI, L.P.

ATLAS VENTURE ASSOCIATES XI, LLC

ATLAS VENTURE OPPORTUNITY FUND I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

  • 10% Owner
2,116,569 2021-03-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BONITA DAVID P - Director see footnotes

2022-06-24 17:32:38 -0400 2022-06-24 P 65,965 $4.37 d 2,002,062 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

BONITA DAVID P - Director see footnotes

2022-06-24 17:32:38 -0400 2022-06-24 P 96,035 $5.37 d 2,098,097 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

ORBIMED ADVISORS LLC - Director see footnotes

ORBIMED CAPITAL GP VI LLC - Director see footnotes

ORBIMED GENESIS GP LLC - Director see footnotes

2022-06-24 17:39:05 -0400 2022-06-24 P 65,965 $4.37 d 2,002,062 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

ORBIMED ADVISORS LLC - Director see footnotes

ORBIMED CAPITAL GP VI LLC - Director see footnotes

ORBIMED GENESIS GP LLC - Director see footnotes

2022-06-24 17:39:05 -0400 2022-06-24 P 96,035 $5.37 d 2,098,097 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

BONITA DAVID P - Director see footnotes

2022-06-24 17:32:38 -0400 2022-06-23 P 23,419 $3.71 d 1,936,097 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

ORBIMED ADVISORS LLC - Director see footnotes

ORBIMED CAPITAL GP VI LLC - Director see footnotes

ORBIMED GENESIS GP LLC - Director see footnotes

2022-06-24 17:39:05 -0400 2022-06-23 P 23,419 $3.71 d 1,936,097 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

BONITA DAVID P - Director see footnotes

2022-06-24 17:32:38 -0400 2022-06-22 P 66,806 $3.55 d 1,912,678 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

ORBIMED ADVISORS LLC - Director see footnotes

ORBIMED CAPITAL GP VI LLC - Director see footnotes

ORBIMED GENESIS GP LLC - Director see footnotes

2022-06-24 17:39:05 -0400 2022-06-22 P 66,806 $3.55 d 1,912,678 indirect -3.8855 -13.4969 4.2945 22.6994 29 -14.1104 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IKENA ONCOLOGY INC IKNA 2022-08-15 22:15:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 21:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 21:15:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 20:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 20:15:03 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 19:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 19:15:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 18:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 18:15:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 17:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 17:15:03 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 16:45:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 16:15:04 UTC -13.5327 15.8527 1600000
IKENA ONCOLOGY INC IKNA 2022-08-15 15:45:04 UTC -13.5327 15.8527 1400000
IKENA ONCOLOGY INC IKNA 2022-08-15 15:15:04 UTC -13.5327 15.8527 1100000
IKENA ONCOLOGY INC IKNA 2022-08-15 14:45:04 UTC -13.5327 15.8527 1100000
IKENA ONCOLOGY INC IKNA 2022-08-15 14:15:03 UTC -13.5327 15.8527 1100000
IKENA ONCOLOGY INC IKNA 2022-08-15 13:45:04 UTC -11.2083 13.5283 1100000
IKENA ONCOLOGY INC IKNA 2022-08-15 13:15:04 UTC -11.2083 13.5283 1100000
IKENA ONCOLOGY INC IKNA 2022-08-15 12:45:04 UTC -11.2083 13.5283 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
LoCorr Investment Trust- LoCorr Dynamic Equity Fund IKNA -5233.0 shares, $-31921.3 2022-03-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund IKNA -1600.0 shares, $-9760.0 2022-03-31 N-PORT

Elevate your investments